UB Paderborn / Katalog / Suche / in CDI

Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)

The American journal of cardiology, 2017-01, Vol.119 (1), p.40-46

2017

Volltextzugriff (PDF)

Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia

Journal of clinical lipidology, 2017-01, Vol.11 (1), p.260-271

2017

Volltextzugriff (PDF)

New LDL-Cholesterol Lowering Therapies: Pharmacology, Clinical Trials, and Relevance to Acute Coronary Syndromes

Clinical therapeutics, 2013-08, Vol.35 (8), p.1082-1098

2013

Volltextzugriff (PDF)

Prevalence of Familial Hypercholesterolemia in Adolescents: Potential Value of Universal Screening?

The Journal of pediatrics, 2016-03, Vol.170, p.315-316

2016

Volltextzugriff (PDF)

Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: A pilot study

Journal of clinical lipidology, 2015, Vol.9 (1), p.42-48

2015

Volltextzugriff (PDF)

Increasing the Detection of Familial Hypercholesterolaemia Using General Practice Electronic Databases

Heart, lung & circulation, 2017-05, Vol.26 (5), p.450-454

2017

Volltextzugriff (PDF)

Optimising the Detection and Management of Familial Hypercholesterolaemia: Central Role of Primary Care and its Integration with Specialist Services

Heart, lung & circulation, 2014-12, Vol.23 (12), p.1158-1164

2014

Volltextzugriff (PDF)

Ten years of lipoprotein apheresis for familial hypercholesterolemia in Malaysia: A creative approach by a cardiologist in a developing country

Journal of clinical lipidology, 2016-09, Vol.10 (5), p.1188-1194

2016

Volltextzugriff (PDF)

Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit

Journal of clinical lipidology, 2015-09, Vol.9 (5), p.703-708

2015

Volltextzugriff (PDF)

Contemporary and Novel Therapeutic Options for Hypertriglyceridemia

Clinical therapeutics, 2015-12, Vol.37 (12), p.2732-2750

2015

Volltextzugriff (PDF)

Under-Recognised and Underestimated: The Cardiovascular Health Burden of Familial Hypercholesterolaemia

Heart, lung & circulation, 2016-11, Vol.25 (11), p.1045-1047

2016

Volltextzugriff (PDF)

Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children

Best Practice & Research Clinical Endocrinology & Metabolism, 2014-06, Vol.28 (3), p.387-403

2014

Volltextzugriff (PDF)

Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?

Cardiology clinics, 2018-05, Vol.36 (2), p.287-298

2018

Volltextzugriff (PDF)

In Memoriam: A cardiologist's unique cholesterol journey in Malaysia

Journal of clinical lipidology, 2016-08, Vol.10 (4), p.737-738

2016

Volltextzugriff (PDF)

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions

Journal of clinical lipidology, 2016-11, Vol.10 (6), p.1329-1337.e3

2016

Volltextzugriff (PDF)

The doctor's dilemma: Challenges in the diagnosis and care of homozygous familial hypercholesterolemia

Journal of clinical lipidology, 2014-11, Vol.8 (6), p.542-549

2014

Volltextzugriff (PDF)

A Web-Based Registry for Familial Hypercholesterolaemia

Heart, lung & circulation, 2017-06, Vol.26 (6), p.635-639

2017

Volltextzugriff (PDF)

NICE Guidance on Familial Hypercholesterolaemia: All Sugar and Spice?

Heart, lung & circulation, 2009-06, Vol.18 (3), p.181-183

2009

Volltextzugriff (PDF)

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance

Journal of the American College of Cardiology, 2014-06, Vol.63 (23), p.2541-2548

2014

Volltextzugriff (PDF)

Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia

Journal of clinical lipidology, 2014-07, Vol.8 (4), p.390-400

2014

Volltextzugriff (PDF)

Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia

Journal of clinical lipidology, 2017-05, Vol.11 (3), p.682-693

2017

Volltextzugriff (PDF)

Intensive LDL Reduction Post Acute Coronary Syndromes: A Catalyst for Improved Outcomes

Heart, lung & circulation, 2016-11, Vol.25 (11), p.1051-1054

2016

Volltextzugriff (PDF)

Detection of Familial Hypercholesterolaemia: A Major Treatment Gap in Preventative Cardiology

Heart, lung & circulation, 2008-10, Vol.17 (5), p.411-413

2008

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)

Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia

New LDL-Cholesterol Lowering Therapies: Pharmacology, Clinical Trials, and Relevance to Acute Coronary Syndromes

Prevalence of Familial Hypercholesterolemia in Adolescents: Potential Value of Universal Screening?

Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: A pilot study

Increasing the Detection of Familial Hypercholesterolaemia Using General Practice Electronic Databases

Optimising the Detection and Management of Familial Hypercholesterolaemia: Central Role of Primary Care and its Integration with Specialist Services

Ten years of lipoprotein apheresis for familial hypercholesterolemia in Malaysia: A creative approach by a cardiologist in a developing country

Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit

Contemporary and Novel Therapeutic Options for Hypertriglyceridemia

Under-Recognised and Underestimated: The Cardiovascular Health Burden of Familial Hypercholesterolaemia

Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children

Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?

In Memoriam: A cardiologist's unique cholesterol journey in Malaysia

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions

The doctor's dilemma: Challenges in the diagnosis and care of homozygous familial hypercholesterolemia

A Web-Based Registry for Familial Hypercholesterolaemia

NICE Guidance on Familial Hypercholesterolaemia: All Sugar and Spice?

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance

Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia

Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia

Intensive LDL Reduction Post Acute Coronary Syndromes: A Catalyst for Improved Outcomes

Detection of Familial Hypercholesterolaemia: A Major Treatment Gap in Preventative Cardiology

Suchergebnisse filtern